Xianzhong Cheng

Publication Activity (10 Years)

Years Active: 2020-2020
Publications (10 Years): 2

Top Topics

Patient Reported

Ejection Fraction

Mitochondrial Dna

Top Venues

Cancer management and research

OncoTargets and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Jing Ni, Yan Wang, Xianzhong Cheng, Fang Teng, Congyang Wang, Suping Han, Xiaoxiang Chen, Wenwen Guo
Pathogenic Heteroplasmic Somatic Mitochondrial DNA Mutation Confers Platinum-Resistance and Recurrence of High-Grade Serous Ovarian Cancer. Cancer management and research 12 (2020)
Jing Ni, Xianzhong Cheng, Jin Chen, Wenwen Guo, Zhiqin Dai
Anlotinib as Exploratory Therapy for Platinum-Resistant Ovarian Cancer: A Retrospective Study on Efficacy and Safety. OncoTargets and therapy 13 (2020)